This trial will examine the outcomes of the mindfulness-based relapse prevention program for 240 people who have completed treatment for opioid or alcohol use disorders. The program integrates mindfulness skills training with cognitive-behavioral relapse prevention strategies.
4 Primary · 9 Secondary · Reporting Duration: Assessed at baseline
240 Total Participants · 2 Treatment Groups
Primary Treatment: Mindfulness Based Relapse Prevention · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: